IDEMIA and Dexus deploy contactless hygienic biometric access control solutions for safe-return-to-work in Sydney office towers

  • IDEMIA MorphoWave™ Compact devices provide a greater and more hygienic user experience thanks to a fully touchless fingerprint verification

  • Several thousand employees use the technology every day at the Gateway and 100 Mount Street office buildings in Sydney

IDEMIA, the global leader in Augmented Identity, today announced that its MorphoWave™ Compact biometric contactless fingerprint reader for access control has been deployed to the Gateway building located at Sydney’s Circular Quay as well as the 100 Mount Street building in North Sydney.

IDEMIA’s MorphoWave™ Compact devices were integrated within the access control and building management at Gateway, delivering secure, frictionless and fast employee access. Gateway is the first office building in Australia to offer fully-integrated, touchless entry technology. Over 30 MorphoWave™ Compact units have been installed at entrances and carparks within the building, replacing traditional swipe cards. With a simple wave of a hand above the fingerprint reader, users are able to open security gates and locker doors, gain carpark access and call lifts without touching the device directly, therefore maintaining better hygiene standards.

MorphoWave™ Compact is IDEMIA’s flagship biometric device for physical access control. It uses patented, touchless 3D fingerprint technology to accurately scan four fingers in 3D within a second when a hand is waved over the reader. It is fully equipped with anti-fraud features such as fake finger detection and banned user lists and can scan and verify up to 50 people per minute, which makes it suitable for secure yet fast access. The device is IP65 rated and Powered over the Ethernet (PoE+), enabling the devices to be installed at both indoor and outdoor locations.

The Gateway building is owned by the Dexus Wholesale Property Fund and is the second Dexus-managed building to install this touchless technology, following the roll-out of MorphoWave™ Compact devices at 100 Mount Street.

Demand for contactless technology has risen as organisations look for ways to seamlessly manage high-traffic environments. With four-finger detection in 3D, high throughput rate, multifactor authentication and easy-to-use interface, our MorphoWave™ Compact device has become the benchmark for frictionless access in some of the most high-security buildings in the world. It is an honour for us to secure more and more buildings in Australia.
Rocky Chow, Head of Biometric Devices business line at IDEMIA Asia Pacific

This touchless entry technology at Gateway and 100 Mount Street is enabling us to deliver a safe, secure and seamless experience for our customers.
Mark Hansen, Chief Information Officer, Dexus

Recently, IDEMIA’s MorphoWave™ technology on Dexus’ The Gateway building was on 9 News:

  • About us - IDEMIA, the global leader in Augmented Identity, provides a trusted environment enabling citizens and consumers alike to perform their daily critical activities (such as pay, connect and travel), in the physical as well as digital space.

    Securing our identity has become mission critical in the world we live in today. By standing for Augmented Identity, an identity that ensures privacy and trust and guarantees secure, authenticated and verifiable transactions, we reinvent the way we think, produce, use and protect one of our greatest assets – our identity – whether for individuals or for objects, whenever and wherever security matters. We provide Augmented Identity for international clients from Financial, Telecom, Identity, Public Security and IoT sectors.
    With close to 15,000 employees around the world, IDEMIA serves clients in 180 countries.

    For more information, visit / Follow @IDEMIAGroup on Twitter

your press contact(s).

Subscribe to our newsletter

Receive our key news and keep up with the trends in our markets by subscribing to our newsletter.

By clicking on the "Subscribe" button, you confirm that you agree to IDEMIA’s Terms of Use and Privacy Policy, and agree to the processing of your personal data and acknowledge your related rights, as described therein.

Your email address will be used exclusively by IDEMIA to send you newsletters related yo your selected topics of interest. In accordance with the law, you have rights of access, rectification and erasure of your personal data, as well as opposition of processing, which can be exercised by writing to